The Metabolomics Core (B) is comprised of a Biosafety Level 3 suite for handling infectious samples, massively parallel detection of mycobacterial metabolites using Time of Flight mass spectrometry (Agilent Accurate Mass ToF 6230), specialized resources for identifying known mycobacterial compounds, and analytical capabilities to discover previously unknown compounds (Agilent Accurate Mass 6520, QTof, Thermo LXQ Advantage 2 Dimensional Ion Trap with MSn). The integrated technologies were assembled by the Moody laboratory and supported a Biomarker Discover Initiative of the Broad Institute, NIH U19 and ROl Projects. Dataflow involves receipt of mycobacteria (Project 3) or patient samples (Project 4), from which total metabolites are extracted and sterilized in organic solvents. Tissue or mycobacterial extracts enter into a liquid chromatography-mass spectrometry system, which was specifically designed to broadly detect the highly diverse and hydrophobic compounds in mycobacteria. In the first phase of whole organism analysis, the platform rapidly detects triplicate intensity values for ~10,000 distinct compounds in each sample. By aligning large datasets derived from different patients, clinical isolates or genetically engineered bacteria, in-house-designed software pipeline identifies all compounds that are changed at statistically significant levels. In a second, targeted phase, all changed compounds are ranked by biological or quantitative criteria to define compounds of interest, whose structures are solved by comparing their masses to the literature (MycoMass) and in-house (MycoMap) databases or are solved through collisional mass spectrometry. This system has discovered previously unknown compounds, identified strain-specific mycobacterial biomarkers in vitro and from tissues and identified lipids changed after gene deletion. This overview describes expansion of the substantial existing core facilities, including a new generation of high accuracy mass spectrometry and expansion of mycobacterial databases, as well as use of the Core to discover biomarkers in drug-resistant or latent mycobacteria or biomarkers of infection.

Public Health Relevance

Mycobacterium tuberculosis is a highly contagious bacterial pathogen, which kills about 1.6 million people per year. This Metabolomics Core (B) can rapidly detect thousands of molecules in Mycobacterium tuberculosis from human patients at the Partners in Health Clinics, providing new methods to rapidly diagnose tuberculosis disease and understand how the bacterium escapes killing by drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI111224-07
Application #
10089399
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2015-02-01
Project End
2022-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
7
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
James, Charlotte A; Yu, Krystle K Q; Gilleron, Martine et al. (2018) CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis. Cell Chem Biol 25:392-402.e14
Mizoguchi, Fumitaka; Slowikowski, Kamil; Wei, Kevin et al. (2018) Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun 9:789
Davenport, Emma E; Amariuta, Tiffany; Gutierrez-Arcelus, Maria et al. (2018) Discovering in vivo cytokine-eQTL interactions from a lupus clinical trial. Genome Biol 19:168
Carette, Xavier; Platig, John; Young, David C et al. (2018) Multisystem Analysis of Mycobacterium tuberculosis Reveals Kinase-Dependent Remodeling of the Pathogen-Environment Interface. MBio 9:
Lehmann, Johannes; Cheng, Tan-Yun; Aggarwal, Anup et al. (2018) An Antibacterial ?-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis. Angew Chem Int Ed Engl 57:348-353
Wun, Kwok S; Reijneveld, Josephine F; Cheng, Tan-Yun et al. (2018) T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids. Nat Immunol 19:397-406
Madigan, Cressida A; Cambier, C J; Kelly-Scumpia, Kindra M et al. (2017) A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy. Cell 170:973-985.e10
Moody, D Branch (2017) How T cells grasp mycobacterial lipid antigens. Proc Natl Acad Sci U S A 114:13312-13314
Brennan, Patrick J; Cheng, Tan-Yun; Pellicci, Daniel G et al. (2017) Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface. Proc Natl Acad Sci U S A 114:8348-8353
Rao, Deepak A; Gurish, Michael F; Marshall, Jennifer L et al. (2017) Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542:110-114

Showing the most recent 10 out of 49 publications